GRAHAM Construction has started work on the £30 million Proton Partners cancer treatment centre in Reading.
The centre, which forms part of the University of Reading’s wider redevelopment of The Thames Valley Science Park, will provide 800,000 sq ft of laboratory and office space as well as creating up to
The Proton Partners cancer treatment centre, which is due for completion at the end of 2017, will be the third to be built in the UK by Proton Partners and will help to meet growing demand for proton beam therapy, a specialised type of cancer treatment that is not yet available in the UK.
“The project includes elements of off-site construction and therefore, it is vital to have a systematic management programme in place. With an extensive portfolio of healthcare projects, our experienced team is looking forward to working with Proton Partners International Ltd to achieve what will prove to be a highly rewarding project.”
Mike Moran, chief executive officer of Proton Partners, said: “We are delighted that our new centre will be built at the heart of one of the most exciting health and life sciences projects in Europe.
“Located just off the M4 corridor and with connections to Heathrow, this centre will make proton beam therapy available to patients from the South of England as well as international patients.
“We’re bringing the top cancer technology to Reading – which is true of all of our treatment centres – and this investment will not only enhance the level of cancer treatment available, but will also bring skilled jobs to the area.”
David Gillham, executive director of Thames Valley Science Park, said: “Thames Valley Science Park is delighted to welcome Proton Partners to its growing community of innovation lead and technology based companies at this exciting new development.
“As well as bringing new healthcare technology to the south east of the UK. We are already exploring wider opportunities for collaboration with the University of Reading.”